Drug intelligence / Profile preview

oxaceprol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Oxaceprol is a small molecule anti-inflammatory drug used primarily for the treatment of osteoarthritis and other degenerative or inflammatory joint disorders, including rheumatoid arthritis and inflammation of connective tissues[1][3][4][5]. It is a derivative of the amino acid proline[2]. Oxaceprol acts by inhibiting the accumulation, adhesion, and migration of leukocytes (white blood cells), particularly neutrophils, into inflamed joints or tissues. This mechanism reduces pain, swelling, stiffness, and other symptoms associated with joint inflammation without significantly inhibiting prostaglandin synthesis—a key difference from traditional NSAIDs[1][6]. Oxaceprol has been shown to be well-tolerated with fewer gastrointestinal side effects compared to conventional NSAIDs. It is available in oral formulations such as tablets or capsules and has been widely used in Europe for over 30 years[7].

Brand names
Oxaproct 600Oxaproct600Oxaproct-600
Other names
N-acetyl-L-hydroxyprolineN-acetyl-4-hydroxyprolineN-acetyl4-hydroxyprolineN-acetyl 4-hydroxyprolineN-acetylhydroxyprolineoxaceprolacetyl hydroxyprolineoxaceprol (cis)-isomer

Beyond the preview

Go deeper on oxaceprol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxaceprol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call